Derek Lowe

  • Opinion

    Column: In the pipeline

    26 October 2011

    Derek Lowe discusses the compounds you can buy but won't see anywhere in the literature

  • Opinion

    Column: In the pipeline

    29 September 2011

    You have to make space for good sense when thinking about safety, argues Derek Lowe

  • Opinion

    Column: In the pipeline

    26 August 2011

    Derek Lowe considers an increasingly popular business strategy in the drug industry, the much discussed 'pay for delay' deal

  • Opinion

    Column: In the pipeline

    28 July 2011

    Derek Lowe highlights the less visible pitfalls on the road to a new drug

  • Opinion

    Column: In the pipeline

    30 June 2011

    The financial markets can be a rollercoaster ride, writes Derek Lowe, so should chemists working in industry worry about the company share price?

  • Opinion

    Column: In the pipeline

    31 May 2011

    To the unfamiliar, chemists might all look the same. But some common categories are easy to identify, explains Derek Lowe

  • Opinion

    Column: In the pipeline

    28 April 2011

    The map of scientific disciplines is growing ever more complex. Derek Lowe surveys the country

  • Opinion

    Column: In the pipeline

    30 March 2011

    'Natural products are back!' is a headline Derek Lowe has seen several times before

  • Opinion

    Column: In the pipeline

    24 February 2011

    Drug discovery is an inherently risky business. Derek Lowe tries to balance some of the risk equations

  • Opinion

    Column: In the pipeline

    31 January 2011

    Enzymes have been giving chemists inferiority complexes since day one, says Derek Lowe. But there's no denying their potential